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Abstract
The physiological response initiates with activation of the hypothalamic-pituitary-
adrenal axis, the autonomic nervous, and the immune systems. All actions promoted 
cellular adaptive changes in cells and tissues that protect the body and promote their 
survival. Diverse protocols of maternal separation (MS) in rodents presented altera-
tions in central nervous system (CNS) such as learning disabilities, voluntary alco-
hol intake, and neurochemical changes. It is believed that the properties of these early 
life procedures are mediated by the high plasticity of the developing CNS. During 
critical development stage, brain regions, mainly those related to aggressive condi-
tions, can have advancement abnormalities occasionally irreversible and thus adjust 
emotional processing when they grow to be adults. Early postnatal period and rela-
tionship between mother and infant are essential of normal stress response and emo-
tional behavior. Probably, it involves the activation of intracellular signaling pathways, 
genome adaptations, adjusts in gene expression, and neural action. The objective of this 
article is to provide an overview of the current state of knowledge in the field focused 
on the maternal separation model, early life experience of postnatal stress, and the 
involvement of γ-aminobutyric acid (GABA) and glutamate transporters.
Keywords: development plasticity, early maternal separation, acute and chronic stress, 
transporters, GABA, glutamate
1. Introduction
Actually, it has been accepted that postnatal exposure to adverse events like stress can influence 
the offspring neurodevelopment, its neuroendocrine, and immune systems and induce behav-
ioral changes thus disturbing neuroplasticity [1, 2].
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The central nervous system (CNS) maintains a degree of adaptive plasticity, which allows adjust-
ing to certain situations and adapting innate designs from neuronal connections. There is an 
abundant bibliography where it is shown that the unfavorable measures in the early life of an 
individual present profound and persistent effects on the cerebral functions, being able to repre-
sent a risky influence for the future development of the psychopathology [4, 5]. Epidemiological 
studies have shown that postnatal stress or emotional trauma, especially when suffering from 
early life, is usually associated with an increased possibility of depression [6]. During the criti-
cal period of certain brain regions, mainly those related to adverse situations, such as the fron-
tal cortex (CF), hippocampus (Hic), and amygdala, hypothalamic-pituitary-adrenal (HPA) axis 
can develop almost irreversible abnormalities and alter the response to stress throughout the 
life of the animal [6, 7]. A recent study of the consequences of maltreatment and stress during 
childhood at early ages has shown the effects of this experience on brain structures. These struc-
tural changes were associated with changes in levels of stress hormones and neurotransmitters, 
resulted in maltreatment and stress in childhood at early ages, a variety of disorders including 
depression, anxiety, aggression, impulsivity, hyperactivity, criminal tendency, or abuse of toxic 
substances [8–11]. With all these evidences, we can deduce that an excess of stress at early ages of 
the developing life restricts with the paused, progressive, and normal development of the brain 
[5, 12, 13].
The brain is vulnerable to early-life programming, and this can be manifested in childhood 
or adulthood as stress hyper-reactivity by deregulation of the HPA axis and increased 
susceptibility to affective disorders like anxiety, depression, and schizophrenia [14, 15]. 
Exposure to early stressful adverse life events may increase vulnerability to psychopathol-
ogy in adult life. There are important memory disturbances in stress-related psychiatric 
disorders [16].
The term neuroplasticity refers to the potential of the brain to reorganize by creating new neu-
ral pathways to adapt, as it needs [2]. This phenomenon requires the stable modulation of gene 
expression, which is mediated at least in part by epigenetic processes such as DNA methyla-
tion and histone modifications. Both the genome and the epigenome cooperate interactively 
in the mature phenotype and determine the sensitivity to environmental factors and the sub-
sequent risk of disease [17–19]. There is increasing evidence that environmental factors, par-
ticularly stressful events experienced early in life, increase the risk of developing a psychiatric 
illness and/or a behavioral disorder [3, 18, 19]. The experiences of chronic stress are a factor 
that mainly influences numerous neuropsychiatric diseases, since it often leads to maladaptive 
responses [20].
While the childhood adversity as a negative childhood experience associated with increased life-
time risk of poorer health and social outcomes have been described postnatal experiences. Several 
studies in psychiatry have shown a long-term negative effect on health and society such as depres-
sion [21], alcohol abuse, use of consumer drugs, family abuse, and other social practices that inter-
act with these processes [22].
The aim of this article is to overview on the current state of knowledge in the field focusing 
an animal model of maternal separation (MS), early life experience of postnatal stress, and the 
involvement of γ-aminobutyric acid (GABA) and glutamate transporters.
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2. Early environmental experiences
The brain in the early stages of development presents a high level of plasticity, facilitating both 
adaptive variations on behalf of opportunities, and malformations alterable vulnerability. At 
present, neuropsychiatric illnesses evident as complex combinations of cognitive, emotional, 
and behavioral discrepancies have their origins of development fixed primary in the initial 
placement of the functional impression of the brain [23]. Postnatal periods are critical for CNS 
development [24]. After birth, the brain continues to grow with its total volume doubling in the 
first year, measured by 15% rise in the second year [25]. In particular, this increase is explained 
by the development of neuronal connections in gray matter (synapses and dendrites), long-
range axons, and myelination; all of these are necessary for the society of circulated functional 
systems; regressive development includes the pruning of the synapses and axons during the 
childhood period, permitting the restructuring of the primarily practical circuits [26].
Animal models are useful tools that help us to understand how genetic vulnerability factors can 
modulate responses to early environmental factors and provide insights into behavioral and 
physiological mechanisms involved in the pathways through which early stress might produce 
long-term effects. In this review, we will focus in the models of MS.
3. Maternal separation
Adverse childhood experience is considered one of the main risk factors for the development of 
psychopathology. Maternal separation in rodents (rats or mice) is a well-known animal model 
of early stress to explore the neuroendocrine and behavioral properties of early difficulty. This 
paradigm discusses to the daily separation of puppies (usually rodents) from their mothers for a 
short period of time (1 hour) or prolonged (3–6 hours) during the first 1–3 weeks after birth. The 
paradigmatic MS puppies remain together as a litter [27]. This process is performed between 
birth and weaning for diverse periods of time and permits a set of experimental designs, which 
vary in the frequency, the duration, and the age at which the MS occurred.
Studies in animal models show the influence of life conditions during the postnatal period in the 
establishment of neurological factors that control behavior and response to stress [28]. Acute and 
chronic MS has both short and long-term effects on behavior and neuroendocrinal responses [29].
Different experimental protocols of MS in rodents have shown changes in CNS functioning: 
learning impediments, voluntary alcohol consumption, and behavioral variations [30]. This han-
dling in animals is used for diverse experiments, for example, Studies in life sciences sometimes 
require repeated manipulation in rodents during the course of the experiment (handling). The 
main function of the handling is to minimize the stress associated with behavioral, pharmaco-
logical and endocrine studies [31–33].
The early life of most mammals is expended in near contact with the mother and for the new-
born. Early MS is a traumatic occurrence that, conditioning on the different situations, can form 
its behavioral and neurochemical phenotype in adulthood. Studies in rodents exhibited that a 
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very short separation cooled by a greater maternal care can completely affect the development of 
offspring. Nevertheless, prolonged MS origins stress. The significance of this stress and HPA axis 
hyper-reactivity is articulated in adulthood and continues throughout the life [34]. MS in rodents, 
particularly in rats, was used as a model for various psychotic conditions, especially depression 
and anxiety [30, 32]. The most popular MS technique of a daily separation of 3 hours from the 
second to the 12th postpartum day produces a model of high-construct depression and predictive 
validity. The results of studies of MS in rat lead to a discussion to its benefits for the neonates. This 
procedure might be contributed for the mental health of the offspring in adulthood [34].
4. Physiological mechanisms involved in early maternal separation: 
neurobiological responses to early life stress
4.1. HPA axis
The hypothalamo-pituitary-adrenal axis is a key component of the stress reaction. Many studies 
have shown the impact of stress exposure during development on the HPA axis activity and on 
psychoemotional disorders during adulthood [19, 35].
Lifelong variations in HPA axis perform examined as a result of developmental complexities 
(maternal separation) demonstrate connections with psychiatric disorders containing schizo-
phrenia depression, which may be characterized by irregularities in the activity of HPA axis 
and reaction to stress [4, 36, 37].
4.2. Neurotrophins reaction
Neurotrophins, also called neurotrophic factors, are a family of proteins that favor the survival 
of neurons. Family members include nerve growth factor (NGF), brain-derived neurotrophic 
factor (BDNF), neurotrophin-3 (NT-3), and neurotrophin 4/5 (NT4/5) [38–40]. During develop-
ment, limiting amounts of neurotrophins function as survival factors to ensure a match between 
the number of surviving neurons and the requirement for appropriate target innervation. In 
addition, they arrange cell destiny decisions, axon growth, dendrite pruning, the pattern of 
innervation, and the expression of proteins critical for normal neuronal role, such as neurotrans-
mitters and ion channels. In the adult CNS, they control synaptic activity and plasticity, while 
ongoing to modulate neuronal survival [41].
4.3. Neurochemical response
Adverse early life practices can provoke neurochemical alterations that may underlie modi-
fications in HPA axis reaction, emotionality, and cognition [42]. The impact of stress on brain 
function is known. Different substances are released in response to stress and can influence 
various neural circuits. The individual effects of functional neuronal mediators of stress (neu-
rotransmitters, neuropeptides, and steroids) and plasticity are integrated. This causes the 
stress instruments to produce an orchestrated “symphony” that allows for adjusted responses 
to the various challenges [42]. Different neurotransmitters, such as NA, 5-HT, Glutamate, and 
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GABA, and neuromodulators, such as neuropeptide Y, oxytocin, a gaseous molecule, and 
nitric oxide, have been implicated in the pathogenesis of stress-dependent disorders in early 
stages of life [43].
We will focus on the GABA and Glutamate neurotransmission, especially in their transporters.
5. γ-Aminobutyric acid (GABA)
γ-aminobutyric acid (GABA) is the chief inhibitory neurotransmitter of the adult mammalian 
CNS. During the early post-natal development, GABA acts as an excitatory neurotransmitter, 
serving as a neuronal and neurotrophic migration factor, separately from taking part in syn-
aptogenesis. The GABAergic system has a large, complete molecular machine, by which it per-
forms its actions, including enzymes for its synthesis and metabolism, membrane receptors, 
and transport proteins. Recent literature demonstrates that GABA transporters, as well as the 
GABAA receptor, are proteins of importance for the normal functioning and development of 
the central nervous system. All these molecules allow GABA to perform an essential function, 
both in the developing brain as in the adult brain. For this reason, the expression profile of the 
different subtypes of the molecules previously mentioned will be described in this article, in 
order to obtain a thorough knowledge of the molecular behavior of the GABAergic system 
from conception to adulthood [44, 45].
During the early postnatal development, GABA acts as an excitatory neurotransmitter, serving 
as a neuronal and neurotrophic migration factor, apart from taking part in synaptogenesis. The 
GABAergic system has a large, complete molecular machine, by which it performs its actions, 
including enzymes for its synthesis and metabolism, membrane receptors, and transport pro-
teins. There is abundant literature showing that GABA transporters, as well as the GABA A 
receptor, are proteins of particular importance for the normal functioning and development of 
the central nervous system [46–49]. GABA-mediated inhibition exerts a powerful control over 
cortical neuronal activity, and GABA transporters (GATs) contribute to modulate the action 
of GABA [45]. Altered GATs activity and/or expression are likely to affect markedly cortical 
function, with their possible involvement in the pathophysiology of selected human disease.
5.1. Transporters of GABA (GATs)
The regulation of extracellular levels of GABA is essential for normal CNS development and 
functioning. The principal mechanism by which the levels of the neurotransmitter are regu-
lated is through Na+-dependent high-affinity uptake carried out by synaptic and glial located 
transporter proteins called GABA transporters [50]. The others GAT-1, GAT-2, and GAT-3 
have been identified from the GATs identified and cloned, although there is also a fourth 
isoform, BGT-1 (Betaine Carrier/GABA). Although all these transporter molecules have high 
affinity and selectivity for GABA, they present differential characteristics in pharmacology, 
localization, and functionality [13, 50, 51]. In fact, the levels of expression during postnatal 
CNS development vary markedly between the two transporters [13, 52]. There is another 
GAT, located intracellularly, which is the vesicular GABA transporter (VGAT), which plays a 
primordial role in the normal development of the immature brain [52].
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• GAT-1: This transporter is one of the most important isoforms of GATs. They are brain-specific 
proteins [53–56]. This transporter has the particularity of being found in both neurons and 
glial cells and is the main isoform of GATs in the mature brain [52].
• GAT-2: It is the least abundant isoform. Although low levels of GAT-2 have been detected 
in GABAergic neurons, this transporter is considered as extraparenchymal and its local-
ization is limited to leptomeningeal and ependymal cells [52, 57]. In all postnatal stages, 
GAT-2 is detected in the arachnoid layer and in the arachnoid trabecula of the subarach-
noid space. In some cases, expression of GAT-2 is observed across the entire diameter of 
the blood vessels supplying the cortex. The latter characteristic occurs mainly between 
postnatal day 0 and 5, and this transporter may be considered as the main source of pe-
ripheral GABA [52].
• GAT-3: This isoform of the GABA transporter is among the most abundant along with GAT-1. 
GAT-3 is the predominant isoform during the early postnatal stages regulating neuronal excit-
ability at these times [52, 58] and has its unique location in astrocytes [52].
• VGAT: The vesicular GABA transporter is essential for GABAergic neurotransmission to oc-
cur, as it introduces GABA into the presynaptic vesicles using a proton gradient. In this way, 
the GABA is stored to be released after the arrival of an action potential to the presynaptic 
terminal [59].
Odeon et al. [60] evaluated the effects of acute MS (AMS) and CMS (Chronic MS) + cold stress 
on the expression levels of GAT-1 in FC and Hic, whose appearance correlates with the concen-
tration of corticosterone at different postnatal day from birth to young adulthood. In response 
to AMS + cold stress in FC, they demonstrated a decrease expression of GAT-1 at PD13. But in 
CMS, the levels of GAT-1 increased both at PD57 and PD63. At AMS in HIc, they observed an 
enhance in GAT-1 expression of either PD7 or PD13. Conversely, CMS decreased either PD57 
or PD67 and increased at PD71 hippocampal levels expression of GAT-1. With respect to the 
levels of corticosterone, they observed an increase in all age groups studied in AMS. On the 
contrary, they showed a decrease in corticosterone levels in CMS. These authors concluded 
that a low responsiveness of the early postnatal period to stress, involvement of GABAergic 
system, suggesting that GATs may contribute to the deregulation of neuronal excitability that 
accompanies at neurobiological consequences of early stress. These dates obtained in this 
experimental condition serve as a starting point, elucidating the molecular mechanism of GAT 
regulation in GABA system throughout postnatal development.
In homogenates of FC and Hic acquired from either acute or chronic MS + cold stress, we 
found variations on the expression of GAT-1. GABA system plays a role in the pathophysiol-
ogy of anxiety and mood disorders. The extracellular levels of GABA are regulated by specific 
high-affinity transporters, one of which, the plasma membrane GAT1, is considered the pre-
dominant neuronal transporter in the rodent brain [56, 61].
Although AMS might mimic a “dramatic” experience occurring at a precise developmental 
stage, the less dramatic repeated maternal separation can reproduce a more physiological 
situation [6].
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The central nervous system maintains a degree of adaptive plasticity, which allows it to adjust 
to certain conditions and modify the innate patterns of neuronal connections [62]. These 
mediators exert a paradoxical damage-protection action. These variations can alter the func-
tioning of the CNS, and consequently, the body’s response to stress throughout life, as this 
treatment is done during the postnatal period, with the CNS in full development. A further 
support to this possibility came from the demonstration that prepulse inhibition disruption in 
maternally deprived rats occurs only after puberty [63, 64], with a temporal profile similar to 
the onset of schizophrenic symptomatology in patients, and was reversed by treatment with 
typical and atypical antipsychotic drugs [34], suggesting that the defects resulting from MS 
might be the consequence of an hyperactivity of the dopaminergic system [65].
The identification of neurobiological substrates that are affected by early life adverse expe-
rience may have important diagnostic implications and could contribute to identify novel 
molecular targets for the development of more effective treatments of psychiatric disorders. 
Further studies are now warranted to elucidate the type or the timing of early life events 
that are associated with enhanced risk for depression or anxiety may be different from those 
relevant to schizophrenia [66].
6. Glutamate
We will briefly describe glutamate as the main excitatory neurotransmitter in the brain. 
There are three families of ionotropic receptors with channels permeable to intrinsic cations: 
N-methyl-D-aspartate (NMDA), α- amino-3-hydroxy-5-methyl-4-isoxazolpropionic acid 
(AMPA), and Kainate. There are three groups of metabotropics, protein G-coupled gluta-
mate receptors (mGluR) that modify neuronal and glial excitability through G-protein sub-
units acting on membrane ion channels and second messengers such as diacylglycerol and 
cAMP. Endogenous glutamate, by activating NMDA, AMPA or mGluR1 receptors, may con-
tribute to acute brain damage following epilepsy, cerebral ischemia, or traumatic brain injury. 
It may also contribute to chronic neurodegeneration in disorders such as amyotrophic lat-
eral sclerosis and Huntington’s chorea. In animal models of cerebral ischemia and traumatic 
brain injury, NMDA and AMPA receptor antagonists protect against acute brain damage and 
delayed behavioral deficits. Other clinical conditions including epilepsy, amnesia, anxiety, 
and psychosis may respond to drugs that act on glutamatergic transmission [67, 68].
6.1. Transporters of glutamate (GluTs)
A family of transporter proteins, excitatory amino acid transporters (EAAT), regulates extra-
cellular concentration of Glu. Several lines of evidence suggest that increases of Glu in extra-
cellular levels are involved in the stress response [68]. Astrocytes are the main protectors of 
neurons from excitotoxicity in the normal CNS, and this protection is conferred by clearance 
of extracellular [69].
The GluTs family is mediated by Na + dependent high affinity, this represents a critical 
factor in the Glu uptake and the regulation of homeostasis in the synaptic cleft [70]. Five 
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high-affinity GluTs were cloned into human and animal tissues and identified as a glutamate 
aspartate transporter (GLAST), excitatory amino acid carrier-1 (EAAT)-1, glial glutamate 
transporter-1 (GLT-1, EAAT-2); excitatory amino acid-carrier-1 (EAAC-1, EAAT-3), EAAT-
4, and EAAT-5. Unlike other neurotransmitters, the action of Glu released into the synaptic 
cleft is terminated by uptake into neurons and surrounding glial cells via specific transport-
ers. Within the nerve terminal, the glutamine released by glial cells and taken up by neurons 
is converted back to Glu [71]. Rapid removal of Glu from the extracellular space is required 
for the survival and normal function of neurons. Although GluTs are expressed by all CNS 
cell types, astrocytes are the cell type primarily responsible for Glu uptake [72]. Astrocytes 
express both GLT-1 and GLAST, while axon terminals in the neocortex only express GLT-1.
Previous studies have indicated that exposure to variable types of stressors during development 
produces persistent behavioral defects that are associated with hormonal, neurotransmitters, 
transporters, and functional changes, and resemble an array of psychopathological conditions.
Altered glutamate receptor (GluR) expression has been implicated in the pathogenesis of stress-
induced disorders. Adrover et al. [73] have shown that glutamate neurotransmission might be 
impaired in the brain of prenatally stressed rats. They observed an increased uptake capacity for 
glutamate in the PFC of prenatal stress males, while no such changes were observed in the Hic. They 
concluded that prenatal stress produced long-term changes in the glutamatergic system, modulat-
ing the expression of glutamate transporters and altering synaptic transmission in the adult brain.
Odeon et al. [74] found that both ethanol intake and activity and protein expression of GluTs 
in certain areas of the rat brain are affected by repeated maternal separation (RMS). Also, they 
demonstrated that RMS increases glutamate uptake in frontal cortex and hippocampus, and 
RMS reduced both GLT-1 and EAAT-3 protein expression and increased GLAST protein levels.
Social loneliness has been used intensively as an animal model to study the consequences of 
social isolation during childhood on the brain and behavior. There is a crucial stage during 
which social isolation has very profound and sometimes irreversible effects.
Recent studies indicate that there are many aspects of alcohol and drug dependence that 
involve changes in glutamate transmission. Different investigations have reported that drugs 
of abuse, including alcohol and cocaine, modify GluTs [75, 76]. The effects of ethanol on glu-
tamate transport may be mediated in part by the level of Ca2+/calmodulin kinase activity [77]. 
Similarly, Othman et al. [78] indicated that in rat cortical astrocytes in vitro ethanol affects 
[3H]-Glutamate uptake by affecting protein kinase C (PKC) modulation of transporter activity.
Odeon et al. [74] observed changes following RMS in the glutamatergic system which could 
be an effect of glucocorticoid. It is known that this hormone may regulate GluT expression 
[79] and ethanol intake [80]. A significant increase in glutamate uptake is observed. However, 
protein levels of the major glial (GLT-1) and neuronal (EAAT-3) transporters declined. It 
should be noted that a third glutamate transporter, GLAST, was found in glia of the frontal 
cortex, and hippocampus was studied. This transporter exhibits increased levels of protein 
expression after treatment. This could be due to the decreased expression of the major gluta-
mate uptake proteins and the probable excitotoxic consequence, which triggered a compensa-
tory mechanism through the increase of GLAST.
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GluTs are neuronal and non-neuronal factors necessary for expression, maintenance, and 
transcriptional regulators of these proteins. The finding that RMS altered Glu regulation in the 
frontal cortex and hippocampus indicates a possible role for distorted glutamate regulation in 
the causal relationship between early life stress. Finally, I have some specific questions about 
this work: (1) Can early exposures with limited time produce lasting physiological changes? 
(2) Can these physiological changes lead to illness? (3) What factors could induce susceptibil-
ity to the adversity of normal development? Responses to these questions should influence 
the awareness of all social areas for the child’s well-being and health throughout life.
7. Conclusions
The findings reviewed here explore some biological mechanisms that could explain the link-
ages between childhood negative experiences, possible diseases, and function of glutamate and 
GABA transporters. These results demonstrate efforts to improve quality of life throughout life. 
With the emergence of new tools, such as the biomarkers of early adversity, this will enable a 
new path of research with the close collaboration of physicians, health professionals, families, 
and communities on the basis of a deep understanding of the long term from early adversity.
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